CERo Therapeutics Holdings (CERo Therapeutics Holdings) Other Operating Expense : $ Mil (TTM As of Dec. 2022)

View and export this data going back to 2024. Start your Free Trial

What is CERo Therapeutics Holdings Other Operating Expense?

CERo Therapeutics Holdings's Other Operating Expense for the six months ended in Dec. 2022 was $-0.00 Mil. CERo Therapeutics Holdings does not have enough years/quarters to calculate its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2022.

CERo Therapeutics Holdings's quarterly Other Operating Expense increased from . 20 ($0.00 Mil) to Dec. 2021 ($-0.00 Mil) but then declined from Dec. 2021 ($-0.00 Mil) to Dec. 2022 ($-0.00 Mil).

CERo Therapeutics Holdings's annual Other Operating Expense increased from . 20 ($0.00 Mil) to Dec. 2021 ($-0.00 Mil) but then declined from Dec. 2021 ($-0.00 Mil) to Dec. 2022 ($-0.00 Mil).

CERo Therapeutics Holdings Other Operating Expense Historical Data

The historical data trend for CERo Therapeutics Holdings's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CERo Therapeutics Holdings Other Operating Expense Chart

CERo Therapeutics Holdings Annual Data

Trend

Dec21

Dec22

Other Operating Expense

CERo Therapeutics Holdings Semi-Annual Data
	Dec21	Dec22
Other Operating Expense	-	-

CERo Therapeutics Holdings Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

CERo Therapeutics Holdings Other Operating Expense Related Terms

Thank you for viewing the detailed overview of CERo Therapeutics Holdings's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

201 Haskings Way, Suite 230, San Francisco, CA, USA, 94080

Website

https://www.cero.bio

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

CERo Therapeutics Holdings (CERo Therapeutics Holdings) Headlines

From GuruFocus

CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients

By Business Wire • 03-07-2024